Systemic effects of IL-6 blockade in rheumatoid arthritis beyond the joints
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic effects of IL-6 blockade in rheumatoid arthritis beyond the joints
Authors
Keywords
Interleukin-6, IL-6 blockade, Rheumatoid arthritis, Systemic effects
Journal
CYTOKINE
Volume 149, Issue -, Pages 155742
Publisher
Elsevier BV
Online
2021-10-22
DOI
10.1016/j.cyto.2021.155742
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis
- (2021) Joshua F Baker et al. ANNALS OF THE RHEUMATIC DISEASES
- Excess mortality persists in patients with rheumatoid arthritis
- (2021) Yeon‐Kyung Lee et al. International Journal of Rheumatic Diseases
- Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study
- (2021) N. Guañabens et al. OSTEOPOROSIS INTERNATIONAL
- The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation?
- (2021) Maria Sole Chimenti et al. Annals of General Psychiatry
- The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill
- (2021) Jennifer M. Knight et al. Translational Psychiatry
- Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease
- (2021) Stefan Schreiber et al. GASTROENTEROLOGY
- Exploring the Role of Interleukin-6 Receptor Inhibitor Tocilizumab in Patients with Active Rheumatoid Arthritis and Periodontal Disease
- (2021) Codrina Ancuța et al. Journal of Clinical Medicine
- Synergistic effect of sarcopenia and poor balance on osteoporotic vertebral fracture in Chinese patients with rheumatoid arthritis
- (2021) Yang-fan Chen et al. CLINICAL RHEUMATOLOGY
- Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors
- (2021) Roy Fleischmann et al. RHEUMATOLOGY
- Interleukin-6: obstacles to targeting a complex cytokine in critical illness
- (2021) Oliver J McElvaney et al. Lancet Respiratory Medicine
- Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs
- (2021) Georg Schett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
- (2020) Alexandre Sepriano et al. ANNALS OF THE RHEUMATIC DISEASES
- Overview of Castleman Disease
- (2020) Angela Dispenzieri et al. BLOOD
- Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study
- (2020) Yutaro Yamada et al. CLINICAL RHEUMATOLOGY
- Translating IL-6 biology into effective treatments
- (2020) Ernest H. Choy et al. Nature Reviews Rheumatology
- Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007–2017
- (2020) Lisa Lindner et al. RHEUMATOLOGY INTERNATIONAL
- The impact of tocilizumab on anxiety and depression in patients with rheumatoid arthritis
- (2020) Shmuel Tiosano et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention
- (2020) Hennie G Raterman et al. EXPERT OPINION ON PHARMACOTHERAPY
- Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study
- (2020) A. Shin et al. OSTEOPOROSIS INTERNATIONAL
- Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis
- (2020) Hiroe Sato et al. Scientific Reports
- Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis
- (2020) Ennio G. Favalli Rheumatology and Therapy
- The burden of pain in rheumatoid arthritis: Impact of disease activity and psychological factors
- (2020) Pascale Vergne‐Salle et al. EUROPEAN JOURNAL OF PAIN
- The prevalence and risk factors of sarcopenia in rheumatoid arthritis patients: A systematic review and meta-regression analysis
- (2020) Tzu-Hao Li et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Effects of Sarilumab on Patient-Reported Impact of Rheumatoid Arthritis Using the Rheumatoid Arthritis Impact of Disease Scale
- (2019) Laure Gossec et al. JOURNAL OF RHEUMATOLOGY
- Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study
- (2019) Ajinkya Pawar et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis
- (2019) Stephanie Finzel et al. ANNALS OF THE RHEUMATIC DISEASES
- Medications associated with fracture risk in patients with rheumatoid arthritis
- (2019) Gulsen Ozen et al. ANNALS OF THE RHEUMATIC DISEASES
- Perioperative management of immunosuppression in patients with rheumatoid arthritis
- (2019) Michael D. George et al. CURRENT OPINION IN RHEUMATOLOGY
- The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study
- (2019) George Markousis‐Mavrogenis et al. EUROPEAN JOURNAL OF HEART FAILURE
- Targeting Interleukin-6 Signaling in Clinic
- (2019) Sujin Kang et al. IMMUNITY
- Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis
- (2019) Benjamin Castagné et al. PLoS One
- Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years’ follow-up
- (2019) Roy Fleischmann et al. RHEUMATOLOGY
- IL-6 INVOLVEMENT IN PAIN, FATIGUE AND MOOD DISORDERS IN RHEUMATOID ARTHRITIS AND THE EFFECTS OF IL-6 INHIBITOR SARILUMAB
- (2019) Fabiola Atzeni et al. PHARMACOLOGICAL RESEARCH
- The impact of fatigue in rheumatoid arthritis and the challenges of its assessment
- (2019) Eduardo J F Santos et al. RHEUMATOLOGY
- Haematological abnormalities in new-onset rheumatoid arthritis and risk of common infections: a population-based study
- (2019) Elena Nikiphorou et al. RHEUMATOLOGY
- Predictors of fatigue in rheumatoid arthritis
- (2019) Katie L Druce et al. RHEUMATOLOGY
- Nonsteroidal anti-inflammatory drugs and cardiovascular risk – a matter of indication
- (2019) Juergen Braun et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Overall infection risk in rheumatoid arthritis during treatment with abatacept, rituximab and tocilizumab; an observational cohort study
- (2019) Kathrine L Grøn et al. RHEUMATOLOGY
- IL-6 trans -signalling mediates trabecular, but not cortical, bone loss after ovariectomy
- (2018) Leah Lazzaro et al. BONE
- Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development
- (2018) David G. Hill et al. INTERNATIONAL JOURNAL OF CANCER
- FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
- (2018) Robert Q. Le et al. ONCOLOGIST
- Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study
- (2018) Yukimi Otsuka et al. PLoS One
- Drug-Induced Gastrointestinal and Hepatic Disease Associated with Biologics and Nonbiologic Disease-Modifying Antirheumatic Drugs
- (2018) Patrick R. Wood et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis
- (2018) Kim Lauper et al. ARTHRITIS CARE & RESEARCH
- Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis
- (2018) Margarida Figueiredo-Braga et al. Journal of Immunology Research
- Sarcopenia
- (2018) Anne Tournadre et al. JOINT BONE SPINE
- IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer’s disease: Systematic Review and Meta-Analysis
- (2018) Ada Ng et al. Scientific Reports
- Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial
- (2018) Yuko Kaneko et al. ANNALS OF THE RHEUMATIC DISEASES
- Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What’s the Difference?
- (2018) Ali Berkant Avci et al. BIODRUGS
- The Two-Faced Cytokine IL-6 in Host Defense and Diseases
- (2018) Masashi Narazaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of tocilizumab on neutrophil function and kinetics
- (2017) Laurence S. C. Lok et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The role of IL-6 in host defence against infections: immunobiology and clinical implications
- (2017) Stefan Rose-John et al. Nature Reviews Rheumatology
- Trial of Tocilizumab in Giant-Cell Arteritis
- (2017) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis
- (2017) Ernest H S Choy et al. RHEUMATOLOGY
- Cardiovascular risk in patients with rheumatoid arthritis
- (2017) Kim Lauper et al. Seminars in Immunopathology
- Selected cytokine pathways in rheumatoid arthritis
- (2017) Mélissa Noack et al. Seminars in Immunopathology
- Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis
- (2017) Anne Tournadre et al. Journal of Cachexia Sarcopenia and Muscle
- Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice
- (2017) Hjalmar Wadström et al. JAMA Internal Medicine
- Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis
- (2017) Mark C. Genovese et al. Arthritis & Rheumatology
- Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors
- (2017) Roy Fleischmann et al. Arthritis & Rheumatology
- Molecular bases of the crosstalk between bone and muscle
- (2017) Gerard Karsenty et al. BONE
- Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis
- (2017) Yi-Ming Chen et al. PLoS One
- Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis
- (2016) Jie Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
- (2016) A Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial
- (2016) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways
- (2016) John A. Sturgeon et al. Nature Reviews Rheumatology
- Patient-Reported Outcomes in Rheumatoid Arthritis
- (2016) Lilian H.D. van Tuyl et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Non-inflammatory Causes of Pain in Patients with Rheumatoid Arthritis
- (2016) Sean D. Boyden et al. Current Rheumatology Reports
- Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments
- (2016) Fenglong Xie et al. Arthritis & Rheumatology
- Ectopic Lymphoid Structures: Powerhouse of Autoimmunity
- (2016) Elisa Corsiero et al. Frontiers in Immunology
- Regulators of Tfh Cell Differentiation
- (2016) Gajendra M. Jogdand et al. Frontiers in Immunology
- Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
- (2015) Cem Gabay et al. ANNALS OF THE RHEUMATIC DISEASES
- The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
- (2015) Christoph Garbers et al. CURRENT OPINION IN IMMUNOLOGY
- IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans
- (2015) Nike Müller et al. JOURNAL OF LIPID RESEARCH
- Longterm Safety of Tocilizumab: Results from 3 Years of Followup Postmarketing Surveillance of 5573 Patients with Rheumatoid Arthritis in Japan
- (2015) K. Yamamoto et al. JOURNAL OF RHEUMATOLOGY
- Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis
- (2015) Jasvinder A Singh et al. LANCET
- Atherosclerosis in rheumatoid arthritis: is it all about inflammation?
- (2015) Sarah Skeoch et al. Nature Reviews Rheumatology
- Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
- (2015) Ryoko Sakai et al. ARTHRITIS RESEARCH & THERAPY
- Hepcidin and Host Defense against Infectious Diseases
- (2015) Kathryn Michels et al. PLoS Pathogens
- Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study
- (2015) Mark C. Genovese et al. Arthritis & Rheumatology
- An Evaluation of Risk Factors for Major Adverse Cardiovascular Events During Tocilizumab Therapy
- (2015) Vijay U. Rao et al. Arthritis & Rheumatology
- Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis
- (2014) Inmaculada del Rincón et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-6 and its receptors: A highly regulated and dynamic system
- (2014) Janina Wolf et al. CYTOKINE
- Tocilizumab Treatment Increases Left Ventricular Ejection Fraction and Decreases Left Ventricular Mass Index in Patients with Rheumatoid Arthritis without Cardiac Symptoms: Assessed Using 3.0 Tesla Cardiac Magnetic Resonance Imaging
- (2014) H. Kobayashi et al. JOURNAL OF RHEUMATOLOGY
- Mechanisms, impact and management of pain in rheumatoid arthritis
- (2014) David A. Walsh et al. Nature Reviews Rheumatology
- IL-6 biology: implications for clinical targeting in rheumatic disease
- (2014) Leonard H. Calabrese et al. Nature Reviews Rheumatology
- Increase of Hemoglobin Levels by Anti-IL-6 Receptor Antibody (Tocilizumab) in Rheumatoid Arthritis
- (2014) Motomu Hashimoto et al. PLoS One
- Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis
- (2014) Barbara Hauser et al. RHEUMATOLOGY
- Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo
- (2014) Helen L. Wright et al. RHEUMATOLOGY
- IL-6 trans-Signaling-Dependent Rapid Development of Cytotoxic CD8+ T Cell Function
- (2014) Jan P. Böttcher et al. Cell Reports
- Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study
- (2013) Burkhard Möller et al. ANNALS OF THE RHEUMATIC DISEASES
- Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
- (2013) Maxime Dougados et al. ANNALS OF THE RHEUMATIC DISEASES
- Thrombocytosis as a Response to High Interleukin-6 Levels in cGMP-Dependent Protein Kinase I Mutant Mice
- (2013) Lin Zhang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis
- (2013) S. Kaptoge et al. EUROPEAN HEART JOURNAL
- Minimal Interleukin 6 (IL-6) Receptor Stalk Composition for IL-6 Receptor Shedding and IL-6 Classic Signaling
- (2013) Paul Baran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan
- (2013) T. Koike et al. JOURNAL OF RHEUMATOLOGY
- Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
- (2013) Cem Gabay et al. LANCET
- Severe hepatitis associated with tocilizumab in a patient with rheumatoid arthritis
- (2013) M. Alfreijat et al. RHEUMATOLOGY
- Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients
- (2013) Soken-Nakazawa J Song et al. ARTHRITIS RESEARCH & THERAPY
- Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis
- (2013) John D Isaacs et al. ARTHRITIS RESEARCH & THERAPY
- Glucocorticoid Dose Thresholds Associated With All-Cause and Cardiovascular Mortality in Rheumatoid Arthritis
- (2013) Inmaculada del Rincón et al. Arthritis & Rheumatology
- Spinal interleukin-6 is an amplifier of arthritic pain in the rat
- (2012) Enrique Vazquez et al. ARTHRITIS AND RHEUMATISM
- A Validated Regulatory Network for Th17 Cell Specification
- (2012) Maria Ciofani et al. CELL
- IL-6 Triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells
- (2012) Sean A Diehl et al. IMMUNOLOGY AND CELL BIOLOGY
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress
- (2012) Milena Girotti et al. PSYCHONEUROENDOCRINOLOGY
- Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study
- (2012) V. Strand et al. RHEUMATOLOGY
- Sleep Loss Exacerbates Fatigue, Depression, and Pain in Rheumatoid Arthritis
- (2012) Michael R. Irwin et al. SLEEP
- Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative
- (2011) L. Gossec et al. ANNALS OF THE RHEUMATIC DISEASES
- A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis
- (2011) A.D. Protogerou et al. ATHEROSCLEROSIS
- Serum Hepcidin: A Direct Link Between Anemia of Inflammation and Coronary Artery Atherosclerosis in Patients with Rheumatoid Arthritis
- (2011) MANAL ALY ABDEL-KHALEK et al. JOURNAL OF RHEUMATOLOGY
- Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE
- (2011) Deborah P. M. Symmons et al. Nature Reviews Rheumatology
- Association between the Interleukin-6 Promoter Polymorphism −174G/C and Serum Lipoprotein(a) Concentrations in Humans
- (2011) Heiner K. Berthold et al. PLoS One
- Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients
- (2011) G Hjeltnes et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Integrated safety in tocilizumab clinical trials
- (2011) Michael H Schiff et al. ARTHRITIS RESEARCH & THERAPY
- Stress activation of IL-6 neurons in the hypothalamus
- (2010) Ryan Jankord et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease
- (2010) S.-N. J. Song et al. BLOOD
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-6: a therapeutic Jekyll and Hyde in gastrointestinal and hepatic diseases
- (2010) S. Danese et al. GUT
- Rheumatoid anemia
- (2010) Charles Masson JOINT BONE SPINE
- Hypothalamic-Pituitary-Adrenal Axis in Rheumatoid Arthritis
- (2010) Richard Imrich et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis
- (2010) D. van Hoogmoed et al. RHEUMATOLOGY
- Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials
- (2010) L. Campbell et al. RHEUMATOLOGY
- Overproduced interleukin 6 decreases blood lipid levels via upregulation of very-low-density lipoprotein receptor
- (2009) M. Hashizume et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
- (2009) G. Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions
- (2009) E Choy et al. ANNALS OF THE RHEUMATIC DISEASES
- Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis
- (2009) Francisco Javier López-Longo et al. ARTHRITIS AND RHEUMATISM
- Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
- (2009) Mike J. L. Peters et al. ARTHRITIS AND RHEUMATISM
- Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis
- (2009) Young Hee Rho et al. ARTHRITIS AND RHEUMATISM
- A Meta-Analysis of Cytokines in Major Depression
- (2009) Yekta Dowlati et al. BIOLOGICAL PSYCHIATRY
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Human Dendritic Cells Induce the Differentiation of Interleukin-21-Producing T Follicular Helper-like Cells through Interleukin-12
- (2009) Nathalie Schmitt et al. IMMUNITY
- The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+T cells
- (2009) Oliver Dienz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Blockade of Interleukin 6 Signaling Induces Marked Neutropenia in Patients with Rheumatoid Arthritis
- (2009) I. NAKAMURA et al. JOURNAL OF RHEUMATOLOGY
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis
- (2009) P. Minnock et al. RHEUMATOLOGY
- Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab
- (2008) M Hirao et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)
- (2008) Aramesh Saremi et al. ATHEROSCLEROSIS
- Transcriptional regulation of autocrine IL-6 expression in multiple myeloma cells
- (2008) Sarah Gerlo et al. CELLULAR SIGNALLING
- Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: Plasma concentrations and relationship to inflammation
- (2008) Junjun Wang et al. CLINICA CHIMICA ACTA
- Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice
- (2008) X. Jin et al. GUT
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
- (2008) Shumpei Yokota et al. LANCET
- Association of catastrophizing with interleukin-6 responses to acute pain
- (2008) Robert R. Edwards et al. PAIN
- Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
- (2008) Bente K. Pedersen et al. PHYSIOLOGICAL REVIEWS
- IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF- and IL-17
- (2008) M. Hashizume et al. RHEUMATOLOGY
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review
- (2008) John Danesh et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search